CDPATH Trademark

Trademark Overview

On Wednesday, July 1, 2020, a trademark application was filed for CDPATH with the United States Patent and Trademark Office. The USPTO has given the CDPATH trademark a serial number of 90030931. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Takeda Pharmaceuticals U.S.A., Inc.. The CDPATH trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Pharmaceutical patient support programs providing inflammatory bowel patients, patient caregivers and healthcare professionals with healthcare information about treatments, disease management, support and counseling; health care and disease management services provided to patients in the nature of disease management programs, namely, monitoring, analyzing and management of patient's health data, treatments and prescriptions
cdpath

General Information

Serial Number90030931
Word MarkCDPATH
Filing DateWednesday, July 1, 2020
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6732492
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements

Goods and ServicesPharmaceutical patient support programs providing inflammatory bowel patients, patient caregivers and healthcare professionals with healthcare information about treatments, disease management, support and counseling; health care and disease management services provided to patients in the nature of disease management programs, namely, monitoring, analyzing and management of patient's health data, treatments and prescriptions

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 30, 2020
Primary Code044
First Use Anywhere DateMonday, May 31, 2021
First Use In Commerce DateMonday, May 31, 2021

Trademark Owner History

Party NameTakeda Pharmaceuticals U.S.A., Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameTakeda Pharmaceuticals U.S.A., Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameTakeda Pharmaceuticals U.S.A., Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, April 14, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 13, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 4, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 10, 2022USE AMENDMENT FILED
Friday, March 4, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 10, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, August 31, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 28, 2021EXAMINER'S AMENDMENT ENTERED
Friday, May 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 28, 2021EXAMINERS AMENDMENT E-MAILED
Friday, May 28, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, May 24, 2021ASSIGNED TO EXAMINER
Wednesday, April 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 22, 2021NON-FINAL ACTION E-MAILED
Friday, January 22, 2021NON-FINAL ACTION WRITTEN
Wednesday, October 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 7, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 7, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 6, 2020ASSIGNED TO EXAMINER
Thursday, July 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 4, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

cdpath management patient disease healthcare health patients treatments programs support provided